This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Cocaine Effects in Humans: Physiology and Behavior - 1

This study has been completed.
Sponsor:
Collaborator:
Columbia University
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000200
First received: September 20, 1999
Last updated: January 11, 2017
Last verified: October 2016
September 20, 1999
January 11, 2017
January 1997
January 1998   (Final data collection date for primary outcome measure)
  • Interaction of cocaine and meds on cardio [ Time Frame: 3 hr ]
  • Interaction of cocaine & meds on coc's subjective [ Time Frame: 3 hr ]
  • Effects of medication on cocaine craving [ Time Frame: 3 hr ]
  • Interaction of cocaine and meds on cardio
  • Interaction of cocaine & meds on coc's subjective
  • Effects of medication on cocaine craving
Complete list of historical versions of study NCT00000200 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cocaine Effects in Humans: Physiology and Behavior - 1
Cocaine Effects in Humans: Physiology and Behavior
The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.
Not Provided
Interventional
Phase 2
Intervention Model: Single Group Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Cocaine-Related Disorders
Drug: Methadone
normal maintenance dose
Not Provided
Foltin RW, Fischman MW. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther. 1996 Sep;278(3):1153-64.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
19
January 1998
January 1998   (Final data collection date for primary outcome measure)
Please contact site for information.
Sexes Eligible for Study: All
18 Years to 45 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00000200
NIDA-03818-1
R01-03818-1
Yes
Not Provided
Not Provided
Not Provided
National Institute on Drug Abuse (NIDA)
Columbia University
Principal Investigator: Marian Fischman, Ph.D. Columbia University
National Institute on Drug Abuse (NIDA)
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP